IRADIMED CORPORATION Reports Strong Third Quarter 2026 Financial Results
IRADIMED CORPORATION reported third-quarter 2026 revenue of $24.2 million, marking a 14% increase compared to the same period in 2025 and an 18% increase from the second quarter of 2026. The company also reported GAAP diluted EPS of $0.51 and non-GAAP diluted EPS of $0.55 for the quarter.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.
Open NewsSnap.ai